Bausch + Lomb Corporation

Bausch + Lomb Corporation is an integrated eye health business that protects and enhances sight globally. Founded in 1853, the company has approximately 13,000 employees and operates in approximately 100 countries. Bausch + Lomb offers a comprehensive portfolio of approximately 400 products, including contact lenses, intraocular lenses (IOLs), other medical devices, surgical systems and devices, vitamin and mineral supplements, lens care products, prescription eye-medications, and other consumer products. These products enable the company to compete across all areas of the eye health market. Bausch + Lomb is a subsidiary of Bausch Health Companies Inc. (BHC), with BHC directly or indirectly holding 310,449,643 Bausch + Lomb common shares, representing approximately 88% of the issued and outstanding common shares as of February 11, 2026. Bausch + Lomb's common shares began trading on the New York Stock Exchange (NYSE) and the Toronto Stock Exchange (TSX) under the ticker symbol "BLCO" on May 6, 2022, following its initial public offering.